CDKN2A and neoplasm: The results showed the expression of tumor malignant characteristic genes such as CDKN2A CKS1B, HSPA9, IDH2, and MYC among different subpopulations of plasma cells [36–40], with high expression in plasma cell_2 (Fig. S7).